Previous Article | Next Article ![]()
Infection and Immunity, August 2001, p. 4790-4798, Vol. 69, No. 8
Division of Pulmonary and Critical Care
Medicine1 and Division of Infectious
Disease and Immunology,2 Department of Medicine,
and Department of Environmental
Medicine,3 New York University School of
Medicine, New York, New York 10016
Received 12 December 2000/Returned for modification 15 February
2001/Accepted 10 May 2001
To better understand the lung and systemic responses of helper T
cells mediating memory immunity to Mycobacterium
tuberculosis, we used three- and four-color flow cytometry to
study the surface phenotype of CD4+ lymphocytes.
Bronchoalveolar lavage (BAL) fluid and peripheral blood (PB) samples
were obtained from a total of 25 subjects, including 10 tuberculosis
(TB)-infected subjects, 8 purified-protein-derivative-negative subjects, and 7 purified-protein-derivative-positive subjects. In marked contrast to CD4+ lymphocytes from PB (9% ± 5%
expressing CD45RA and CD29), the majority (55% ± 16%) of
CD4+ lymphocytes in BAL (ALs) simultaneously expressed
CD45RA, a naïve T-cell marker, and CD29, members of the very
late activation family. Further evaluation revealed that
CD4+ ALs expressed both CD45RA and CD45RO, a memory T-cell
marker. In addition, the proportion of CD4+ lymphocytes
expressing CD69, an early activation marker, was drastically increased
in BAL fluid (83% ± 9%) compared to PB (1% ± 1%), whereas no
significant difference was seen in the expression of CD25, the
low-affinity interleukin 2 receptor (34% ± 15% versus 40% ± 16%).
More importantly, we identified a minor population of
CD69bright CD25bright CD4+
lymphocytes in BAL (10% ± 6%) that were consistently absent from PB
(1% ± 1%). Thus, CD4+ lymphocytes in the lung
paradoxically coexpress surface molecules characteristic of
naïve and memory helper T cells as well as surface molecules
commonly associated with early and late stages of activation. No
difference was observed for ALs obtained from TB-infected and
uninfected lung segments in this regard. It remains to be determined if
these surface molecules are induced by the alveolar environment or if
CD4+ lymphocytes coexpressing this unusual combination of
surface molecules are selectively recruited from the circulation. Our data suggest that ex vivo experiments on helper T-cell subsets that
display distinctive phenotypes may be pivotal to studies on the human
immune response to potential TB vaccines.
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.8.4790-4798.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
In Situ Activation of Helper T Cells in the
Lung

*
Corresponding author. Mailing address: OB-C&D Rm 646, Bellevue Hospital, 462 First Ave., New York, NY 10016. Phone:
(212) 263-8848. Fax: (212) 263-0584. E-mail:
tsed01{at}med.nyu.edu.
Present address: State University of New York, Downstate Medical
Center, Brooklyn, NY 11203-2098.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»